Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. nerve activating
Show results for
Products
Services
Applications

Companies

News
Articles

Refine by
Date

  • Older

Nerve Activating Articles & Analysis

15 news found

Axogen to Participate at Upcoming Investor Conferences

Axogen to Participate at Upcoming Investor Conferences

Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result ...

ByAxogen (AXGN)


Axogen, Inc. to Report Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call on February 22, 2022

Axogen, Inc. to Report Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call on February 22, 2022

Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result ...

ByAxogen (AXGN)


Publication of Two-Year EVOKE Double-Blind Randomized Controlled Trial Results in JAMA Neurology Demonstrate Sustained Superiority of EvokeĀ® Closed-Loop over Open-Loop Spinal Cord Stimulation

Publication of Two-Year EVOKE Double-Blind Randomized Controlled Trial Results in JAMA Neurology Demonstrate Sustained Superiority of EvokeĀ® Closed-Loop over Open-Loop Spinal Cord Stimulation

The limitation of open-loop SCS systems is the lack of adjustment to the broad range of electrical field strength reaching the spinal cord due to changes in distance between the stimulation electrode and the nerves. These changes in distance are caused by normal physiological activity (e.g., breathing and heartbeat) and movement, which results in variable ...

BySaluda Medical Pty Ltd.


Axogen, Inc. to Participate at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

Axogen, Inc. to Participate at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result ...

ByAxogen (AXGN)


Axogen, Inc. to Participate at Jefferies London Healthcare Conference

Axogen, Inc. to Participate at Jefferies London Healthcare Conference

Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result ...

ByAxogen (AXGN)


SetPoint Medical Appoints Amy Derosier as Vice President of Clinical Affairs

SetPoint Medical Appoints Amy Derosier as Vice President of Clinical Affairs

The company is developing a novel bioelectronic medicine platform designed to stimulate the vagus nerve to activate the inflammatory reflex to produce a systemic immune-restorative ...

BySetpoint Medical Corporation


Runway Growth Capital Announces a Senior Secured Term Loan of $35 Million to SetPoint Medical

Runway Growth Capital Announces a Senior Secured Term Loan of $35 Million to SetPoint Medical

The company is pioneering a new treatment paradigm, using electrical pulses that activate the body’s innate “inflammatory reflex,” for rheumatoid arthritis (RA), Crohn’s disease and other chronic autoimmune diseases as a safe, cost-effective alternative to drugs and biologics. ...

BySetpoint Medical Corporation


SetPoint Medical CEO Murthy Simhambhatla Named to AIMBE College of Fellows

SetPoint Medical CEO Murthy Simhambhatla Named to AIMBE College of Fellows

The company is developing a novel bioelectronic medicine platform that stimulates the vagus nerve to activate the inflammatory reflex to produce a systemic immune-restorative ...

BySetpoint Medical Corporation


SetPoint Medical Receives FDA Breakthrough Device Designation for its Novel Bioelectronic Platform

SetPoint Medical Receives FDA Breakthrough Device Designation for its Novel Bioelectronic Platform

SetPoint’s investigational bioelectronic medicine platform stimulates the vagus nerve to activate the endogenous inflammatory reflex and thereby reduce inflammation. ...

BySetpoint Medical Corporation


The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile for a Novel Bioelectronic Device in patients with Drug Refractory Rheumatoid Arthritis

The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile for a Novel Bioelectronic Device in patients with Drug Refractory Rheumatoid Arthritis

Device reduced disease activity in 50% of patients who had failed multiple drug classes including Janus Kinase Inhibitors (JAKi) SetPoint Medical, Inc. today announced that data from a first-in-human pilot trial that evaluated its proprietary Vagus Nerve Stimulation (VNS) microregulator in a cohort of patients with multi-drug refractory rheumatoid arthritis ...

BySetpoint Medical Corporation


The Lancet Rheumatology publishes clinical trial data demonstrating promising safety and efficacy profile for a Novel Bioelectronic Device in patients with drug refractory rheumatoid arthritis

The Lancet Rheumatology publishes clinical trial data demonstrating promising safety and efficacy profile for a Novel Bioelectronic Device in patients with drug refractory rheumatoid arthritis

Device reduced disease activity in 50% of patients who had failed multiple drug classes including Janus Kinase Inhibitors (JAKi) SetPoint Medical, Inc. today announced that data from a first-in-human pilot trial that evaluated its proprietary Vagus Nerve Stimulation (VNS) microregulator in a cohort of patients with multi-drug refractory rheumatoid arthritis ...

BySetpoint Medical Corporation


SetPoint Medical Receives IDE Approval for U.S. Pivotal Trial to Study its Bioelectronic Platform in Rheumatoid Arthritis Patients

SetPoint Medical Receives IDE Approval for U.S. Pivotal Trial to Study its Bioelectronic Platform in Rheumatoid Arthritis Patients

The company is developing a novel bioelectronic medicine platform that stimulates the vagus nerve to activate the inflammatory reflex to produce a systemic immune-restorative effect. ...

BySetpoint Medical Corporation


SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019

SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019

The company is developing a novel bioelectronic medicine platform that stimulates the vagus nerve to activate the inflammatory reflex to produce a systemic immune-restorative effect. ...

BySetpoint Medical Corporation


SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019

SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019

The company is developing a novel bioelectronic medicine platform that stimulates the vagus nerve to activate the inflammatory reflex to produce a systemic immune-restorative effect. ...

BySetpoint Medical Corporation


Setpoint Medical announces oral presentation of results from U.S. Pilot Study in Rheumatoid Arthritis Patients at American College of Rheumatology (ACR) Annual Meeting 2019

Setpoint Medical announces oral presentation of results from U.S. Pilot Study in Rheumatoid Arthritis Patients at American College of Rheumatology (ACR) Annual Meeting 2019

Details of the oral presentation include: Neurostimulation for Treatment of Drug Refractory Rheumatoid Arthritis: A First-in-Human Study Using a Novel Vagus Nerve Stimulator Session: 3S109 RA – Treatments II: Novel Treatments for RA Presenter: Norman B. ...

BySetpoint Medical Corporation

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT